Примери за използване на Regular human на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
I'm a regular human who wants to live a good life.
It's like it's some sort of crime now, being a regular human.
The right dose of a regular human is 2 phen375 pills.
One unit of insulin glulisine has the same glucose-lowering activity as one unit of regular human insulin.
The correct dose of a regular human being is two phen375 tablets.
Similar reductions were seen in the second study in adults,which compared Apidra with regular human insulin.
The appropriate dosage of a regular human being is 2 phen375 tablets.
Peter can cling to most surfaces, has superhuman strength andis 15 times more agile than a regular human.
Pharmacokinetic profile of insulin glulisine and regular human insulin in type 1 diabetes mellituspatients after a dose of 0.15 U/ kg.
The glucose excursion(AUC 0-6h) was 641 mg. h. dl-1 for insulin glulisine and 801mg.h. dl-1 for regular human insulin.
Pharmacokinetic profiles of insulin glulisine and regular human insulin in patients with type 1 diabetes after a dose of 0.15 Units/kg.
The craniums of the Paracas skulls are least 25% larger andup to 60% heavier than the skulls of regular human beings.
Figure 3: Pharmacokinetic Profiles of Insulin Glulisine and Regular Human Insulin in Patients with Type 2 Diabetes after a Subcutaneous Dose of 0.2 units/kg.
Insulin aspart has a low binding to plasma proteins(< 10%),similar to that seen with regular human insulin.
After subcutaneous administration, insulin glulisine is eliminated more rapidly than regular human insulin with an apparent half-life of 42 minutes compared to 86 minutes.
Insulin aspart has a low binding affinity to plasma proteins(< 10%),similar to that seen with regular human insulin.
A phase I study carried out with insulin glulisine,lispro and regular human insulin in an obese population has demonstrated that insulin glulisine maintains its rapid-acting properties.
In all four studies, Apidra was compared with other insulins orinsulin analogues(regular human insulin or insulin lispro).
The distribution and elimination of insulin glulisine and regular human insulin after intravenous administration is similar with volumes of distribution of 13 l and 22 l and half-lives of 13 and 18 minutes, respectively.
Symptoms of influenza A(H1N1)v in humans are usually similar to regular human seasonal influenza symptoms.
In adults with type 2 diabetes, there was a decrease in HbA1c of 0.46% after six months of Apidra,compared with 0.30% for regular human insulin.
A crossover studycomparing insulin glargine plus lispro insulin to NPH plus regular human insulin(each treatment administered for 16 weeks in random order) in 26 adolescent type 1 diabetic patients aged 12 to 18 years was also performed.
When given 2 minutes prior to meal,insulin glulisine provided better postprandial control than regular human insulin given 2 minutes before the meal.
Studies in healthy volunteers and patients with diabetes demonstrated that APIDRA has a more rapid onset of action anda shorter duration of activity than regular human insulin when given subcutaneously.
When given 2 minutes prior to meal,insulin glulisine provided better postprandial control than regular human insulin given 2 minutes before the meal.
Studies in healthy volunteers and patients with diabetes demonstrated that insulin glulisine is more rapid in onset of action andof shorter duration of action than regular human insulin when given subcutaneously.
Administered 2 minutes before the meal gives similar postprandial glycemic control compared to regular human insulin given 30 minutes before the meal.
In a randomised, controlled clinical study, paediatric patients(age range 6 to 15 years)with type 1 diabetes(n=349) were treated for 28 weeks with a basal-bolus insulin regimen where regular human insulin was used before each meal.
Administered immediately before a test meal,insulin glulisine provided better postprandial control than regular human insulin, as in adults(see section 5.1).
In a randomised, controlled clinical study, paediatric patients(age range 6 to 15 years) with type 1 diabetes(n=349)were treated for 28 weeks with a basal-bolus insulin regimen where regular human insulin was used before each meal.